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Migratory non-lymphoid tissue dendritic cells (NLT-
DCs) transport antigens to lymph nodes (LNs) and
are required for protective immune responses in the
context of inflammation and to promote tolerance to
self-antigens in steady-state. However, themolecular
mechanisms that elicit steady-state NLT-DCmatura-
tion and migration are unknown. By comparing the
transcriptomeofNLT-DCs in the skinwith theirmigra-
tory counterparts in draining LNs, we have identified
a novel NF-kB-regulated gene network specific to
migratory DCs. We show that targeted deletion of
IKKb in DCs, a major activator of NF-kB, prevents
NLT-DC accumulation in LNs and compromises reg-
ulatory T cell conversion in vivo. This was associated
with impaired tolerance and autoimmunity. NF-kB is
generally considered the prototypical pro-inflamma-
tory transcription factor, but this study describes a
role for NF-kB signaling in DCs for immune homeo-
stasis and tolerance that could have implications in
autoimmune diseases and immunity.
INTRODUCTION
Our skin and mucosal tissues, such as lung and intestine, are
continually exposed to foreign antigens and microorganisms in
our diet and the environment. Maintenance of tissue homeosta-
sis is dependent upon the immune system’s ability to remain
tolerant of these antigens and commensal microflora while re-
taining the ability to mount the appropriate immune responses
to pathogenic microorganisms upon infection or injury. Defects
in this delicate balance can lead to the development of chronic
tissue inflammation and autoimmune diseases.
Dendritic cells (DCs) are key regulators of both protective im-
mune responses and tolerance to self-antigens (Steinman et al.,2003). In steady state, two main groups of DCs can be distin-
guished according to their location and migratory capacity.
Resident lymphoid-tissue (LT)-DCs include plasmacytoid DCs
(pDCs) and CD8a+ and CD11b+ conventional DCs (cDCs).
Non-lymphoid tissue (NLT)-DCs, found in the parenchyma of tis-
sues, also include CD8a-type and CD11b+ cDC subsets. How-
ever, in steady-state a fraction of NLT-DCs migrate through the
lymphatics to draining lymph nodes (LNs), where they are classi-
fied as migratory NLT-DCs (migDCs). NLT-DCs in mucosal tis-
sues and skin regulate both immune tolerance and the response
to invading pathogens by virtue of their ability tomigrate to drain-
ing LNs and transport antigens. In steady-state, this function
promotes the expansion of inducible regulatory T (iTreg) cells,
required for tolerance to self-antigens (Azukizawa et al., 2011;
Guilliams et al., 2010). However, in the context of inflammation,
these cells can transport self or foreign antigens and promote
pathogenic or protective T cell responses, respectively (Bedoui
et al., 2009; Henri et al., 2010).
The molecular mechanisms that regulate NLT-DC migration
in steady state are poorly understood. Accumulation of migDCs
in draining LNs is dependent on expression of the chemokine
receptor CCR7 and its ligands CCL21 and CCL19, which are
highly expressed in lymphoid tissues and present all along
the lymphatic endothelium (Ohl et al., 2004). It has been
proposed that NLT-DCs undergo a ‘‘limited’’ maturation pro-
gram that results in upregulated expression of CCR7 and
subsequent migration in steady-state (Lutz and Schuler,
2002). The functional maturation of DCs has been widely
studied in the context of microbial stimuli or pro-inflammatory
cytokines, which promote morphological, phenotypic, and
functional changes required for the effective priming and acti-
vation of naive T cells. Migratory NLT-DCs undergo similar
morphological and phenotypic changes, including increased
expression of MHC class II and CD40. But in contrast with
DC maturation during inflammation, the steady-state matura-
tion of NLT-DCs is associated with induction of tolerance rather
than T cell priming and activation. However, the signaling path-
ways that regulate steady-state NLT-DC maturation remain an
enigma.Immunity 42, 627–639, April 21, 2015 ª2015 Elsevier Inc. 627
Comparing the transcriptional program of resident NLT-DCs
to their migratory LN counterparts, we have identified a
novel NF-kB-regulated gene network specific to steady-state
migratory DCs that includes genes previously shown to regulate
migration and Treg cell conversion. Although the NF-kB pathway
is thought to play a prominent role in DC activation in the context
of microbial stimuli and pro-inflammatory cytokines (Dev et al.,
2011), the role of NF-kB in homeostatic DC maturation had not
been addressed. We therefore generated mice with a targeted
deletion of IkB kinase b (IKKb) in the DC lineage—a critical regu-
lator of NF-kB activation. We found that IKKb deletion in DCs
results in dis-regulated immune homeostasis and spontaneous
autoimmunity. Moreover our studies show that homeostatic
NF-kB signaling is required for the steady-state accumulation
of migratory DCs in draining LNs and maintenance of immune
tolerance to tissue antigens. This represents a new and unex-
pected role for NF-kB in immune homeostasis and tolerance
that could have important implications in host defense and
autoimmune diseases.
RESULTS
Steady-State Migratory NLT-DCs Activate a
NF-kB-Regulated Gene Network
Migratory NLT-DCs (migDCs) are critical for both T cell priming in
the context of inflammation and tolerance to innocuous tissue
antigens in steady-state. But the molecular pathways that regu-
late NLT-DC maturation and migration are unknown. Skin
contains two major DC populations, epidermal Langerhans
cells (LCs) and dermal DCs (dDCs), the latter of which can be
divided into three subsets (CD11bloCD207, CD11bloCD207+,
and CD11bhiCD207) that represent more than 60% of all
dDCs (Henri et al., 2010). Migratory counterparts of all four pop-
ulations are found in the cutaneous LNs (CLNs) draining the skin.
To investigate the genes and signaling pathways that are
specifically associated with steady-state migDCs from the
skin, we examined the global gene expression profiles of
skin-resident CD11bhiCD207CD64 dDCs and their migratory
counterparts in the CLNs from published microarray data
(Tamoutounour et al., 2013). We found several hundred genes
that were differentially expressed between migDCs in the
CLNs and their resident counterparts in the dermis (Figures
1A and S1). Ingenuity Pathway Analysis (IPA) revealed that
this set of genes was significantly enriched for annotations
pertaining to ‘‘DC maturation’’ and for targets of the ‘‘NF-kB
complex’’ (Figure 1A). Moreover, by using distant regulatory
elements (DiRE) analysis, we found that NF-kB was the tran-
scription factor most significantly associated with the migDC-
specific gene signature (Figure 1B). The over-representation
of NF-kB binding motifs in these genes was also confirmed
by Clover (cis-element overrepresentation) analysis with a p
value of 103 (Figure 1C). The vast majority of these genes
were validated as bona fide NF-kB target genes in DCs by pre-
vious ChIP-seq analysis of RelA binding sites during TLR-
induced DC maturation (Figure 1D; Garber et al., 2012). To
further analyze the commonalities between the strong NF-kB
signature in DCs during TLR-induced maturation and the
NF-kB-associated gene signature in steady-state migDCs, we
compared the fold changes in expression of all validated628 Immunity 42, 627–639, April 21, 2015 ª2015 Elsevier Inc.RELA-target genes from TLR-induced DC maturation (Garber
et al., 2012) and predicted NF-kB targets induced in steady-
state migDCs, compared to their tissue-resident counterparts.
This comparison revealed a strong association between TLR-
induced DC maturation and high expression of canonical NF-
kB target genes, such as Il1b, Il1a, Il6, Il12a, Il12b, and Tnfsf1a
(Figure 1E). In contrast, these genes were not highly expressed,
or even repressed, in steady-state migDCs. Reciprocally, many
of the predicted NF-kB target genes that were induced specif-
ically in migDCs (Fscn1, Il15ra, Aldh1a2, and Il4i1) were not
regulated during LPS-induced DC maturation, and several
genes were in fact strongly repressed in LPS-activated DCs
(Sox4, Idh1). This indicates a NF-kB-regulated gene network
in migDCs that is likely to have unique upstream regulators.
These analyses suggest that NF-kB activation might control
the steady-state maturation of NLT-DCs through regulation of
a novel gene network that is distinct from its function in DCmatu-
ration during inflammation or infection.
Targeted Deletion of IKKb in DCs Leads to Spontaneous
Autoimmunity
To examine the role of NF-kB signaling in NLT-DCs, we gener-
ated mice with a targeted deletion of IKKb (Ikbkb) in the DC line-
age. IkbkbF/F mice were crossed with Tg(Itgax-Cre) mice, which
express Cre recombinase from the CD11c (Itgax) promoter (Ca-
ton et al., 2007). Homozygous IkbkbDItgax/DItgax (IkbkbDItgax) mice
were born in normal Mendelian ratios and we confirmed efficient
deletion of IKKb expression specifically in DCs by analysis of
both mRNA and protein expression (Figure S2). From adulthood,
IkbkbDItgax mice presented with frequent LN adenopathy and
splenomegaly (Figures 2A and 3A). HE staining and immuno-
histochemical (IHC) analysis of spleens from IkbkbDItgax mice
showed a dramatic increase in B cell follicle germinal centers
(GCs), marked by PNA staining, compared to littermate controls
(Figure 2B), reflecting an increase in antigen-induced B cell pro-
liferation. In addition, there was a striking increase in the infiltra-
tion of DCs into the T cell zone of B cell follicles in IkbkbDItgax mice
(Figure 2C), suggesting increased DC-mediated T cell activation.
Polyclonal B cell activation was associated with the presence
of anti-nuclear antibodies (ANA) in the serum of IkbkbDItgax
mice (Figure 2D), a common indicator of autoimmune disease.
Another frequent manifestation of autoimmune disease is the
deposition of immune complexes in glomeruli of the kidney,
which subsequently trigger inflammation and glomerular
nephritis. IHC analysis also revealed glomerular antibody depo-
sition (IgG) in the kidneys of IkbkbDItgax mice, whichwas absent in
littermate controls (Figure 2C). Collectively, these data suggest
that inhibition of steady-state NF-kB signaling in DCs results in
spontaneous autoimmunity.
IKKb in DCs Regulates Immune Homeostasis
To further characterize the autoimmune phenotype in IkbkbDItgax
mice, we performed flow cytometry analysis on LN and spleen
cell suspensions. This revealed a significant increase in propor-
tions of neutrophils (PMNs), Ly6Chi ‘‘inflammatory’’ monocytes,
and B cells compared to IkbkbF/F control mice (Figure 3B). In
contrast, the proportions of CD8+ and CD4+ T cells were signif-
icantly reduced in LNs (Figure 3B). Resident LT-DCs play an
important role in maintaining immune homeostasis (Birnberg
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Figure 1. A NF-kB-Regulated Gene Network in Steady-State Migratory DCs
(A) Heat map showing the expression pattern of upregulated genes in migDCs from CLNs compared to dermal DCs (dDCs). Relative expression values are
represented for the genes of the ‘‘DC maturation’’ pathway (black) and the upstream regulator ‘‘NF-kB complex’’ (black bold), based on IPA. Genes that are
common to both analyses are in bold red.
(B) Diagram showing the top 10 transcription factor motifs enriched in migDC-upregulated genes. The occurrence represents percent of genes with a conserved
binding site for the TRANSFAC transcription factors. The importance is the product between the occurrence and the weight assigned to each transcription factor.
(C) The consensus NF-kB binding motif (MA0061.1) was used for Clover analysis that revealed a significant enrichment in genes upregulated in migDCs; p value
and score are indicated.
(D) Venn diagram showing the overlap between the migDC-upregulated genes with RelA target genes identified in LPS-stimulated DCs by ChIP-seq analyses
(Garber et al., 2012).
(E) Scatter plot comparing fold changes (log2) in the expression of bona fide NF-kB target genes (based on RELA binding) and putative NF-kB target genes in
steady-state migDCs, as shown in (D). LPS-stimulated DCs (y axis) and steady-state migDCs (x axis). Examples of canonical pro-inflammatory NF-kB target
genes upregulated in LPS-stimulated DCs and newly identified NF-kB target genes specifically regulated in migDCs are highlighted by red circles.et al., 2008), but we found no significant differences in numbers
of LT-DCs in LNs and spleen from IkbkbDItgax mice (Figure 3C).
The proportions of CD11b+ and CD8+ LT-DC subsets was also
not altered in IkbkbDItgax mice, but there was a decrease in the
frequency of CD4+ DCs among the CD11b+ subset and a recip-
rocal increase in CD4CD11b+ DCs (Figure S3). These data
showed that IKKb signaling was not required LT-DC develop-
ment or survival.CD11c is expressed throughout the DC lineage, including
monocyte-derived DCs (moDCs), but also by somemacrophage
populations (Miller et al., 2012). To assess the role of IKKb
more specifically in cDCs, we compared IkbkbDItgax mice with
IkbkbDLyz2 mice, where IKKb is deleted in lysozyme M (Lyz2)-
expressing myeloid cells, including macrophages, PMNs, and
moDCs, but is not highly expressed in cDCs (Figure S2). Although
IkbkbDLyz2 mice also showed some degree of splenomegaly,Immunity 42, 627–639, April 21, 2015 ª2015 Elsevier Inc. 629
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Figure 2. IKKb Deficiency in DCs Leads to Spontaneous Autoimmunity
(A) Spleen and CLNs of IkbkbF/F and IkbkbDItgax mice. Abbreviations are as follows: BLN, brachial LN; ILN, inguinal LN; AxLN, axillary LN; ALN, auricular LN.
(B) Spleen sections were analyzed by HE and PNA histochemistry, GC development was scored in n = 4 mice.
(C) Spleen sections were analyzed for Ter119, CD11c, and CD3 staining by IHC (left), kidney sections were analyzed by HE (middle), and IgG deposition by IHC
(right); scale bars represent 100 mm.
(D) Anti-nuclear autoantibodies (ANA) were measured in serum from IkbkbF/F and IkbkbDItgax mice. Statistical analysis was performed with a Fischer exact test.compared to littermate controls, they did not present with LN
adenopathy or increased LN cellularity (Figure 3A). Furthermore,
flow cytometry analysis did not reveal any significant changes in
the proportions of B cells or T cells in LN and spleen from
IkbkbDLyz2 mice in contrast to IkbkbDItgax mice (Figure 3B). There
was a slight increase in the proportions of PMNs and Ly6C+
monocytes in LN and spleen from IkbkbDLyz2 mice (Figure 3B).
These data indicate that IKKb signaling in cDCs is not required
for LT-DC development or survival in steady-state but has an
important role in maintaining immune homeostasis.
IKKb in DCs Regulates Treg Cell Accumulation in CLNs
DCs contribute to the maintenance of immune tolerance by
regulating the accumulation of Treg cells. There are two major
populations of Treg cells in mice: natural Treg (nTreg) cells pro-
duced in the thymus and iTreg cells generated in peripheral
lymphoid organs. Thymus-dependent nTreg cells provide cen-
tral tolerance to self-antigens expressed by thymic medullary630 Immunity 42, 627–639, April 21, 2015 ª2015 Elsevier Inc.epithelial cells (mTECs), and there might also be a role for
thymic DCs in nTreg cell selection through the cross-presen-
tation of mTEC-associated antigens. In the periphery, naive
T cells can be converted to iTreg cells by DC-mediated antigen
presentation (Steinman et al., 2003). To assess the role of IKKb
in DCs for Treg cell accumulation, we measured the number of
CD25+FOXP3+CD4+ Treg cells in thymus, spleen, and CLNs of
IkbkbDItgax and littermate IkbkbF/F control mice. There was a sig-
nificant reduction in the proportion of Treg cells in CLNs from
IkbkbDItgax mice compared to littermate controls (Figure 3D),
but the proportions of Treg cells in the spleen and thymus
were not affected (Figure 3D). However, the frequency of
L-selectin (CD62L)-expressing Treg cells was significantly
reduced in spleen, whereas NRP1+ (neuropillin) thymus-depen-
dent nTreg cells were unaffected (Figure S3). This suggests that
IKKb in DCs contributes to iTreg cell conversion and activation
in the periphery and particularly in CLNs that acquire antigens
from the skin.
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Figure 3. Targeted Deletion of IKKb in DCs Disrupts Immune Homeostasis
Flow cytometry analysis of spleen and CLNs from IkbkbF/F, IkbkbDItgax, and IkbkbDLyz2 mice.
(A–C) Total cell number (A), proportions of immune cells represented as the ratio between IkbkbF/F and IkbkbDItgaxmice (B), and percentage of resident LT-DCs (C).
(D) Proportions of Foxp3+CD4+ cells in thymus, spleen, and CLN.
Data are shown as mean ± SEM; graphs represent pooled data from at least three independent experiments. Statistical analysis was performed with Mann-
Whitney test; *p < 0.05, **p < 0.01, ***p < 0.001, ****p < 0.0001.IKKb Is Required for Steady-State NLT-DC
Accumulation in the CLNs
The generation of iTreg cells in CLNs is dependent on migratory
NLT-DCs (migDCs) from the dermis that transport antigens to the
CLNs in steady-state (Azukizawa et al., 2011; Guilliams et al.,
2010). These migDCs can be distinguished from resident LT-
DCs on the basis of their MHCIIhiCD11cintCCR7+ phenotype.
We measured the accumulation of migDCs in the CLNs from
IkbkbDItgax mice and littermate controls by flow cytometry.
IkbkbDItgax mice showed a dramatic reduction in accumulation
of migDCs, whereas the proportion of resident LT-DCs was un-
affected (Figures 4A and 3C). The specificity of the analysis for
migDCs was confirmed with CLNs from CCR7-deficient mice(Ccr7/), which lack migDCs in draining LNs (Figure 4A; Ohl
et al., 2004). We also performed IHC analysis on LN sections
from IkbkbDItgax mice; this analysis confirmed the lack of accu-
mulation of CD207+ skin-derived DCs in the T cell zone of the
LN (Figure 4B). These data clearly showed that IKKb expression
in DCs is required for the steady-state accumulation of migDCs
in the CLNs.
To evaluate the role of IKKb in NLT-DC development and
homeostasis, we analyzed the distribution of NLT-DCs in the
epidermis (LCs) and dermis (dDCs). IHC analysis showed no
change in LC number or distribution in epidermis from IkbkbDItgax
mice (Figure 4B). FACS analysis of dermal cell suspensions also
showed no significant differences in the frequency of dDCs inImmunity 42, 627–639, April 21, 2015 ª2015 Elsevier Inc. 631
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Figure 4. IKKb Is Required for Accumulation of migDCs in Steady-State
(A) Flow cytometry analysis of CLNs from IkbkbF/F, IkbkbDItgax, and Ccr7/ mice. Resident LT-DCs and migDCs were distinguished by MHCII and CD11c
staining, representative FACS plots are shown, and the graph represents pooled data from three independent experiments. Statistical analysis was performed
with Mann-Whitney test; ***p < 0.001.
(B) Sections of intact CLNs were stained for CD207, LYVE1, B220, and CD11c and analyzed by confocal microscopy. Representative images are shown; scale
bars indicate 200 mM.
(C) Ear epidermal sheets were stained for MHCII and CD3 and epidermal DCs counted from at least three fields (n = 6). Lower panels: Dermal cell suspensions
were prepared and stained forMHCII, CD45.2, andCD3. Plots represent CD45.2 gated cells, the total number of DCs/ear from three independent experiments are
represented in the graph.
(D) BrdU was administered i.p. daily for 7 consecutive days. On day 3 and 7, mice were sacrificed, dermal and epidermal cell suspensions from the ears were
prepared, cellswere stained asdescribed in (C), andBrdU+ incorporationbyDCswasdetermined.Graphs represent twopooled independent experiments of n=3.
(E) Tg(Itgax-Bcl2) mice were crossed with IkbkbDItgax mice to generate mice overexpressing BCL2 in DCs (Tg(Bcl2)) and proportions of resDCs and migDCs in
CLNs were analyzed as described in (A); data are shown asmean ± SEM of n = 5 and are representative of at least 2 independent experiments. Statistical analysis
was performed with Mann-Whitney test; ***p < 0.001.IkbkbDItgax mice (Figure 4B). Moreover, the different dDC subsets
were present in similar proportions as littermate control mice
(Figure S4). These data showed that IKKb was not required for632 Immunity 42, 627–639, April 21, 2015 ª2015 Elsevier Inc.the development or accumulation of NLT-DCs in the skin. Previ-
ous studies have estimated the half-life of NLT-DCs in the dermis
to be between 3 and 5 days, being constantly replenished from
circulating common dendritic cell progenitors (CDPs) that
develop in the bone marrow (Poulin et al., 2007). On the other
hand, epidermal LCs are maintained by self-renewal in the tissue
with little contribution from blood-borne progenitors (Poulin
et al., 2007). To assess the role of IKKb in NLT-DC turnover,
we used in vivo BrdU labeling. Epidermal LCs and dermal DCs
from IkbkbDItgax mice showed no difference in BrdU incorpora-
tion compared with littermate controls during a 7 day labeling
period (Figure 4C), indicating that IKKb deletion does not affect
the proliferation or turnover of skin DCs in steady-state.
The experiments described above clearly showed that IKKb
deletion in DCs did not affect the homeostasis of NLT-DCs in
the skin, yet there was a dramatic absence of migDCs in
CLNs. This presented the possibility that IKKb might regulate
migDC survival in the draining LN after maturation and migration
from the skin. To address this question, we crossed IkbkbDItgax
mice to transgenic mice that expressed the anti-apoptotic pro-
tein Bcl2 specifically in the DC lineage (Tg(Itgax-Bcl2)) (Gautier
et al., 2009). The proportions of DCs in the dermis were not
significantly altered in IkbkbF/F or IkbkbDItgax mice expressing
the Bcl2 transgene (Figure 4E). However, although there was a
significant increase in the accumulation of migDCs in CLNs
from IkbkbF/F mice expressing the Bcl2 transgene, this did not
rescue the defect inmigDC accumulation in IkbkbDItgax mice (Fig-
ure 4E). These studies demonstrate that the accumulation of
migDCs in steady state is limited by apoptotic cell death; how-
ever, rescuing cell survival is not sufficient to restore migDC
accumulation in the absence of IKKb signaling, suggesting that
IKKb activation in steady-state migDCs drives the maturation
andmigration of NLT-DCs from the skin and not their persistence
in the CLNs.
IKKb Regulates Spontaneous Maturation of NLT-DCs in
the Skin
Steady-state NLT-DC maturation is associated with the upre-
gulation of major histocompatibility complex II (MHCII) and
co-stimulatory molecules such as CD40 on migratory DCs. Cul-
ture of intact skin explants ex vivo results in spontaneous DC
maturation and the acquisition of migratory properties that
can be measured by DC emigration into the culture medium.
The number of DCs that emigrated from skin explants of
IkbkbDItgax mice was significantly reduced compared to litter-
mate controls (Figure 5A). Emigrated DCs from IkbkbDItgax
mice showed no difference in Annexin V staining, suggesting
that the reduced emigration was not due to effects on cell sur-
vival (Figure 5B). Culture of intact skin explants also results
in accumulation of DCs along dermal lymphatic vessels in
a CCR7-dependent manner, forming so-called dermal cord
structures (Ohl et al., 2004; Weinlich et al., 1998); however, ex-
plants from IkbkbDItgax mice showed no defect in dermal cord
formation compared to skin from littermate control mice (Fig-
ure 5C). In contrast, those structures were absent from the
dermis of skin explants from Ccr7/ mice (Figure 5D), as pre-
viously described by Ohl et al. (2004), suggesting that IKKb
is not required for CCR7-mediated sensing of chemokines ex-
pressed by lymphatic endothelium. This is supported by the
increased accumulation of LT-DCs in the T cell zones of splenic
B cell follicles in IkbkbDItgax mice (Figure 2C), which is also
CCR7 dependent (Ohl et al., 2004).To further examine the role of IKKb in spontaneous matura-
tion of skin DCs, we isolated epidermal and dermal DCs from
IkbkbDItgax mice and littermate controls and measured their
phenotype ex vivo. The isolation and culture of skin DCs at
37C, without exogenous stimulation, was sufficient to induce
the upregulation of typical markers of maturation including sur-
face expression of MHCII, CD40, and CCR7, as well as intracel-
lular expression of the actin bundling protein FASCIN (Fscn1)—
which has been shown to be required for migration of mature
DCs (Yamakita et al., 2011) and to be a putative NF-kB-regulated
gene in steady-state migDCs (Figure 1A). IKKb-deficient DCs
showed no difference in upregulation of MHCII or survival upon
culture ex vivo (Figure 5E) but showed reduced expression
of CD40, CCR7, and FASCIN compared to wild-type cells (Fig-
ure 5E), demonstrating that IKKb contributes to the intrinsic
spontaneous maturation of isolated skin DCs. Furthermore,
addition of specific small molecule inhibitor of IKKb (Zhang
et al., 2014) blocked the spontaneous maturation of isolated
dermal DCs in this context (Figure S5).
Finally, to confirm the IKKb-dependent expression of putative
NF-kB target genes upregulated in steady-state migDCs, we
performed quantitative PCR analysis of mRNA expression in iso-
lated dermal DCs before and after spontaneous maturation. We
confirmed the IKKb-dependent induction of several predicted
NF-kB target genes during spontaneous maturation of dermal
DCs, including Fscn1 and Aldh1a2, but not the canonical pro-
inflammatory target gene Tnfsf1a, which was in fact downregu-
lated during spontaneous maturation (Figure 5F).
These studies demonstrate that IKKb activation regulates the
spontaneous maturation of skin DCs ex vivo and the upregula-
tion of genes specifically associated with steady-state migDCs,
including genes required for migration and Treg cell conversion.
Steady-State NLT-DC Migration Does Not Depend on
Canonical NF-kB Stimuli
Thesignaling pathways that regulate steady-stateNLT-DCmatu-
ration are unknown. The canonical NF-kBpathway ismostwidely
studied in the context of TNF-a, IL-1b, and TLR signaling (Dev
et al., 2011), so todetermine the role of thesepathways in homeo-
static NLT-DC migration, we analyzed CLNs from Myd88/
Trif/mice, deficient in all TLR-signaling pathways and signaling
through the IL-1 receptor, and frommice deficient in both TNF-a
receptors (Tnfsfr1/Tnfsfr2/). We found no defects in the
accumulation of migDCs in either of these strains (Figure S6).
This is in keepingwith our analysis of the transcriptional signature
of steady-state migDCs, which indicates that the NF-kB-regu-
lated gene network in migDCs is distinct from the network of
NF-kB-regulated genes during TLR-induced DCmaturation (Fig-
ure 1E). In addition, Ingenuity Pathway Analysis (IPA) with the
genes differentially expressed by migDCs compared to their tis-
sue-resident counterparts showed a negative enrichment for
known upstream regulators of pro-inflammatory NF-kB signaling
(Figure S1), indicating that the ‘‘canonical’’ NF-kB pathway is in
fact downregulated in these cells.
The alternative NF-kB pathway, leading to activation of RELB
p52 heterodimers, has also been suggested to play an important
role in DC maturation (Azukizawa et al., 2011; Shih et al., 2012).
The alternative pathway is normally dependent on IKKa activa-
tion and not IKKb, but a recent study showed that IKKb canImmunity 42, 627–639, April 21, 2015 ª2015 Elsevier Inc. 633
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F
Figure 5. IKKb Regulates Spontaneous Skin NLT-DC Maturation
(A and B) Ear skin flaps from IkbkbF/F and IkbkbDItgax mice were floated on tissue culture medium for 72 hr and DC emigration was analyzed by flow cytometry; (A)
represents total emigrated DCs per ear and (B) the percentage of Annexin V+ cells among emigrated DCs.
(legend continued on next page)
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regulate activation of RELB in DCs after lymphotoxin b (LTb)
stimulation (Shih et al., 2012). We found no defect in accumula-
tion of migDCs in the CLN of IKKaAA knock-in mice (Mancino
et al., 2013), which express an inactive mutant of IKKa (Fig-
ure S6). Furthermore, blockade of LTbR signaling through the
administration of LTbR-Ig fusion protein had no impact on
migDC accumulation in CLNs (Figure S6). These data indicate
that the alternative NF-kB pathway and LTbR signaling through
either IKKa or IKKb is not required for the steady-state migration
of NLT-DCs in the skin.
IKKb Regulates Dermal NLT-DC Migration and Antigen
Trafficking to CLNs
Migratory dermal NLT-DCs transport antigens from the skin
to the CLNs for subsequent presentation to naive T cells.
To confirm the role of IKKb in NLT-DC migration to the CLNs,
we applied FITC epicutaneously to the ear skin of IkbkbF/F and
IkbkbDItgax mice andmeasured the accumulation of FITC-labeled
migDCs in the CLNs. Previous studies have established that all
FITC+ DCs in the CLNs via this procedure represent migratory
dDCs or LCs (Ohl et al., 2004). As expected, we observed a
profound defect in accumulation of FITC+ DCs in the CLNs
from IkbkbDItgaxmice compared to littermate controls (Figure 6A).
Because FITC acts as a hapten, forming adducts with endoge-
nous proteins, these data suggest that IKKb deficiency in NLT-
DCs would result in impaired trafficking of antigens from the
skin to theCLNs. To test the role of IKKb inNLT-DC-mediated an-
tigen presentation and T cell priming in the CLNs, we applied the
TLR7 agonist R848, as an adjuvant, in combination with MHC I-
restricted ovalbumin peptide (OVAp) to the ear skin of IkbkbDItgax
and littermate control mice; we then measured the expansion of
OVAp-specificCD8+ T cells in theCLNs by FACSby usingOVAp-
specific tetramers. There was a significant reduction in antigen-
specific CD8+ T cell expansion in CLNs from IkbkbDItgax mice
compared to littermate controls (Figure 6B), demonstrating that
impaired NLT-DC migration in IkbkbDItgax mice prevented the
transport and presentation of an exogenous antigen applied to
the skin. In addition, the significant increase in NLT-DCmigration
promoted by R848 application was impaired in IkbkbDItgax mice
(Figure 6C), suggesting that IKKb is required for NLT-DC migra-
tion in both steady-state and inflammatory conditions.
T cell priming upon sub-cutaneous (s.c.) immunization with the
commonly used adjuvant CFA is dependent on recruitment
of monocyte-derived DCs (moDCs) into draining LNs through
high endothelial venules (HEVs) (Nakano et al., 2009)—as
opposed to migration of NLT-DCs through lymphatics. We did(C and D) Ear skin flaps were floated on tissue culture medium for 72 hr befo
Quantitative analysis was performed with ImageJ software and data are plotted
represent 100 mm. Graphs represent pooled data from at least three independ
**p < 0.01, ***p < 0.001.
(E) Epidermal and dermal cell suspensions were prepared and cultured overnight
Fascin expression by flow cytometry. The first graphs represent the ratio of viable
and Fascin expression by epidermal and dermal DCs are shown at 4C and aft
because they were uniformly expressed by DCs. CCR7 and Fascin expression are
at 37C. Data are shown as mean ± SEM and are representative of three indepen
*p < 0.05.
(F) Dermal cell suspensions were prepared as described in (E); DCs were sorted
expression of specific genes in dermal DCs at 4C and 37C is indicated norm
replicates from pooled cells of n = 3 mice and are representative of two indepennot observe any defect in the accumulation of OVAp-specific
CD8+ T cells in the CLNs of IkbkbDItgax mice after s.c. immuniza-
tion with CFA and OVA, and moDC accumulation in CLNs was
not affected in IkbkbDItgax mice (data not shown). These data
suggest that IKKb is not required for the recruitment of moDCs
or subsequent T cell priming in inflammatory conditions, but spe-
cifically regulates the maturation and migration of NLT-DCs.
IKKb in DCs Promotes Tolerance to an Endogenous
Tissue Antigen
In steady state, migratory NLT-DCs are required for conversion
of naive CD4+ T cells to FOXP3+ Treg (iTreg) cells and tolerance
to self-antigens (Azukizawa et al., 2011; Guilliams et al., 2010).
IkbkbDItgax mice showed a profound absence of steady-state
migDCs and significantly reduced accumulation of FOXP3+
Treg cells (Figures 4A and 3D). The data described above
show that IKKb signaling in NLT-DCs is required for the transport
and presentation of exogenous antigens from the skin in the
draining LNs. To evaluate the role of IKKb in skin NLT-DCs for
tolerance to an endogenous self-antigen, we used K5-mOVA
transgenic mice (Tg(K5-mOVA)), which express membrane-
bound OVA in epidermal keratinocytes (Azukizawa et al.,
2003). Previous studies with K5-mOVA mice have shown that
migratory NLT-DCs are required for the transport and presenta-
tion of OVA antigens from the skin to naive T cells in the CLNs. In
the case of CD8a-type migDCs, this was required for cross-pre-
sentation of OVA-peptide to autoreactive CD8+ T cells and their
subsequent deletion (Waithman et al., 2007). However, in the
case of CD11b+ migDCs, this was required for the conversion
of OVA-specific naive CD4+ T cells to iTreg cells (Azukizawa
et al., 2011; Guilliams et al., 2010). To test the role of IKKb in
this process, we generated K5-mOVA mice with a targeted
deletion of IKKb in DCs (Tg(K5-mOVA) IkbkbDItgax). First, we
confirmed the absence of migDCs in CLNs from Tg(K5-mOVA)
IkbkbDItgax mice compared to Tg(K5-mOVA) IkbkbF/F littermate
controls (Figure 7A). This was associated with a significant
reduction in the accumulation of CD25+FOXP3+ Treg cells in
the CLNs of Tg(K5-mOVA) IkbkbDItgax mice (Figure 7A). To test
the role of IKKb in migDCs for deletion of autoreactive CD8+
T cells, we adoptively transferred purified OVA-specific CD8+
T cells (OT-I) to cohorts of Tg(K5-mOVA) IkbkbDItgax and Tg(K5-
mOVA) IkbkbF/F mice and monitored the deletion of OT-I cells
in the blood and CLNs by FACS, using specific tetramers. All
control mice deleted adoptively transferred OT-I cells within
2 weeks (Figure 7B); however, OT-I cells expanded in a signifi-
cant proportion of mice with IKKb deletion in DCs (Figure 7B),re dermis was separated from epidermis and stained for MHCII and LYVE1.
as proportion of MHCII+ cells co-localized to Lyve1+ lymphatics. Scale bars
ent experiments. Statistical analysis was performed with Mann-Whitney test;
at 37C. DCs were counted and stained for viability, MHCII, CD40, CCR7, and
DCs upon culture at 37C compared to cells kept at 4C. MHCII, CD40, CCR7,
er culture at 37C. MHCII and CD40 expression are represented as MFI only,
expressed as proportion of positive cells among DCs andMFI of positive cells
dent experiments. Statistical analysis was performed with Mann-Whitney test;
and mRNA expression analyzed by quantitative RT-PCR (qRT-PCR). Relative
alized to cyclophillin (CPH) expression. Data represent mean ± SEM of three
dent experiments.
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Figure 7. IKKb in DCs Regulates Tolerance to an Endogenous Cell-
Associated Antigen in the Skin
(A) The proportions of migDCs and Foxp3+ Treg cells in CLNs from Tg(K5-
mOVA)/IkbkbDItgax mice and Tg(K5-mOVA)/IkbkbF/F littermates was evaluated
by flow cytometry. Graphs represent pooled data from three independent
experiments.
(B) Purified OVA-specific CD8 T cells (OT-I) were transferred to Tg(K5-mOVA)/
IkbkbDItgax and Tg(K5-mOVA)/IkbkbF/F mice and the proportion of activated
OT-I cells measured in peripheral blood after 11 days by flow cytometry using
tetramers. Data from four independent experiments are represented on the
graph. Each point corresponds to one mouse.
(C) Purified naive CD25CD4+OT-II cells were adoptively transferred to Tg(K5-
mOVA)/IkbkbDItgax and Tg(K5-mOVA)/IkbkbF/F mice, and after 13 days the
proportion of CD25+FOXP3+ OT-II cells among CD4+ cells in the CLN was
evaluated by flow cytometry.
Data are representative of three independent experiments. Statistical analyses
in (A) and (C) were performed with Mann-Whitney test; **p < 0.01, ***p < 0.001,
****p < 0.0001. Statistical analysis in (B) was performed by Fischer exact test;
*p < 0.05.
A
B
C
Figure 6. IKKb Is Required for Dermal NLT-DC Migration and
Antigen Trafficking to CLNs
(A) FITC was applied epicutaneously to the ear skin of IkbkbF/F and IkbkbDItgax
mice, and 3 days later the accumulation of FITC-labeled DCs in draining ALNs
was measured by flow cytometry. Representative data showing the percent-
age and the number of FITC+ DCs are plotted from three independent ex-
periments.
(B) Mice were immunized by topical application of R848 on the ear in combi-
nation with MHC I-restricted ovalbumin peptide (OVAp). After 7 days, the
expansion of OVAp-specific CD8+ T cells was measured in the ALN by cy-
tometry using tetramers. Graphs represent pooled data from three indepen-
dent experiments and show the percentage and the number of OVAp-specific
CD8+ T cells in ALNs.
(C) R848was applied to the ears and accumulation ofmigDCs in draining ALNs
after 2 days was evaluated by flow cytometry. Representative data showing
the percentage and the number of migDCs from three independent experi-
ments are shown.
Statistical analysis was performed with Mann-Whitney test; **p < 0.01, ***p <
0.001, ****p < 0.0001.indicating impaired deletional tolerance. In fact, the expansion of
adoptively transferred autoreactive CD8+ T cells in Tg(K5-mOVA)
IkbkbDItgax mice frequently led to inflammatory lesions in the skin
as a result of the activation of autoreactive CD8+ T cells (data not
shown).
To evaluate the role of IKKb-dependent migDCs in the conver-
sion of naive OVA-specific CD4+ T cells to iTreg cells, we adop-
tively transferred purified naive CD25CD4+ OT-II cells to
cohorts of Tg(K5-mOVA) IkbkbDItgax and Tg(K5-mOVA) IkbkbF/F
mice and measured the accumulation of CD25+FOXP3+ OT-II636 Immunity 42, 627–639, April 21, 2015 ª2015 Elsevier Inc.cells in theCLNs. In these experiments, Tg(K5-mOVA) IkbkbDItgax
mice showed a profound impairment in accumulation of
OT-II iTreg cells compared to littermate controls (Figure 7C),
demonstrating that IKKb-dependent migDCs were required for
OVA-specific iTreg cell conversion in CLNs.
Collectively, these data demonstrate that IKKb-dependent
accumulation of migDCs in the CLNs in steady state plays
an important contribution to tolerance toward endogenously
expressed cell-associated antigens by regulating both iTreg
cell conversion, through MHCII-mediated presentation to naive
CD4+ T cells, and deletional tolerance, through cross-presenta-
tion of cell-associated antigens to CD8+ T cells.
DISCUSSION
The homeostatic maturation of NLT-DCs and their subsequent
migration from the tissue parenchyma to the draining LNs is crit-
ical tomaintain tolerance to innocuous tissue antigens. Triggering
of pattern recognition receptors (PRRs), such as TLRs, on DCs is
well known to induce a process of functional maturation that is
required for the priming of naive T cells. Similar changes are asso-
ciated with steady-state migDCs compared to their tissue-resi-
dent counterparts, but results in tolerogenic activity rather than
T cell priming. However, the signaling pathways that regulate
the maturation and accumulation of migDCs in steady state
have remained an enigma. Here we have shown that NF-kB
signaling is required for thesteady-statematurationandmigration
of NLT-DCs and we demonstrate that IKKb deletion in DCs was
sufficient to prevent the steady-state accumulation of migDCs
from the skin. Deletion of IKKb did not affect DC development
or survival but was critically required formaturation andmigration
of NLT-DCs in the skin. Furthermore, the IKKb-dependent accu-
mulation of migDCs played an important role in tolerance toward
endogenously expressed cell-associated antigens by regulating
both iTregcell conversion, throughMHCII-mediatedpresentation
tonaiveCD4+Tcells, anddeletional tolerance, throughcross-pre-
sentation of cell-associated antigens to CD8+ T cells.
Our analysis of the specific gene expression signature in
steady-state migDCs reveals a strong enrichment for NF-kB-
regulated genes. However, canonical NF-kB target genes that
are highly expressed upon TLR-induced DC maturation were
not upregulated or were even repressed, indicating a novel NF-
kB-regulated gene network in migDCs that is likely to depend
on unique upstream regulators. In keeping with this hypothesis,
we showed that mice deficient in TLR, IL-1b, or TNF-a signaling
had no defects in accumulation ofmigDCs in steady state. This is
in accordance with a previous study that showed no alterations
in migDC accumulation or maturation in germ-free mice and
mice deficient in TLR signaling (Wilson et al., 2008). The NF-
kB-regulated gene network in steady-state migDCs from the
skin included genes previously linked with DC migration
(Fscn1) and Treg cell conversion (Aldh1a2), both functions that
were impaired in vivo upon deletion of IKKb in DCs, as well as
several genes with no known function in DCs.
One possible explanation for the distinct networks of NF-kB-
regulated genes during steady-state (tolerogenic) and Toll-like
receptor (TLR)-induced (immunogenic) DC maturation might be
the context-specific activation or expression of transcriptional
co-regulators. For example, the transcription factor IRF4 was
recently shown to be required for development of CD11b+
NLT-DCs in both skin and intestine and the steady-state accu-
mulation of migDCs in CLNs and MLNs, respectively (Persson
et al., 2013; Schlitzer et al., 2013). IRF4 and NF-kB are known
to interact in B cells and co-operatively regulate specific genes.
We have also found significant enrichment for IRF binding sites in
genes upregulated in steady-state migDCs (Dalod et al., 2014),
suggesting that IRF4 and NF-kB might co-operatively regulate
steady-state NLT-DC maturation.
The homeostatic signals that drive NLT-DC maturation and
the accumulation of migratory DCs are completely unknown. In
fact, it isn’t even clear whether this is an intrinsically stochastic
process or one driven by instructive signals in the tissue micro-environment. Factors that have been suggested to play a role
in NLT-DC homeostasis and maturation include CSF2 (GM-
CSF) and TGF-b. CSF2 was shown to promote the survival of
NLT-DCs and thus affect the accumulation of migDCs in draining
LNs (Greter et al., 2012), but we found no role for IKKb in NLT-DC
survival, and furthermore, blocking CSF2 failed to prevent the
spontaneousmaturation of dermal DCs ex vivo, which was abro-
gated by inhibition of IKKb (Figure S5). TGF-b has been linked
with tolerogenic functions in DCs (Travis et al., 2007) and plays
a critical role in the homeostasis of LCs in the epidermis (Kel
et al., 2010). However, we also found that TGF-b neutralization
did not affect spontaneous maturation of dermal DCs ex vivo
in contrast to IKKb inhibition (Figure S5).
Several previous studies have suggested that WNT-b-catenin
signaling in DCs is important for tolerogenic function (Jiang et al.,
2007; Manicassamy et al., 2010). Targeted deletion of b-catenin
in DCs led to impaired Treg cell conversion by DCs in the intes-
tine and disruption of immune homeostasis (Manicassamy et al.,
2010). However, these authors focused on NLT-DCs in the intes-
tine lamina propria and did not analyze migDCs from the mesen-
teric LNs. Our analysis shows that WNT-b-catenin target genes
are in fact downregulated in migDCs from the CLNs compared
to their dermal counterparts (Figure S1), indicating that this
pathway is not upregulated during steady-state DC maturation
in the skin. This might reflect tissue specificity in pathways
regulating NLT-DC maturation, or alternatively, WNT-b-catenin
signaling might affect DC function independently of NLT-DC
maturation and migration. Another link between WNT-b-catenin
signaling and tolerogenic DC maturation was suggested by
Jiang et al. (2007), when these authors showed that disruption
of homotypic E-cadherin interactions between clusters of
bone-marrow-derived DCs (BMDCs) in culture led to b-cate-
nin-mediated maturation, including upregulation of CCR7,
CD40, and CD86. This maturation was associated with tolero-
genic function rather than T cell priming. We generated
IKKb-deficient BMDCs but found no impact on cluster-disrup-
tion-induced maturation, including upregulation of CCR7,
CD40, and CD86 (data not shown). Furthermore, a number of
the genes induced by BMDCs in this context were in fact down-
regulated in migDCs from the skin compared to dermal DCs
(Figure S1), as were other WNT-b-catenin pathway genes.
In summary, we have uncovered a new role for NF-kB
signaling in the accumulation of steady-state migDCs and
maintenance of immune tolerance in the skin. Although NF-kB
is generally considered as a major pro-inflammatory transcrip-
tion factor, these data show an important role for NF-kB
signaling in immune homeostasis and tolerance that could be
significant in the context of autoimmune diseases and can-
cer—where the molecular mechanisms regulating tolerance to
tissue antigens are therapeutic targets. Our analysis of the
global gene expression profile of NLT-DCs and their migratory
counterparts suggests that a novel NF-kB-regulated gene
network is associated with the steady-state maturation of
NLT-DCs and their tolerogenic function; however, the homeo-
static signals that trigger IKKb-NF-kB activation in this context
are yet to be revealed. Future characterization of the upstream
regulators and key nodes in this network might reveal new mo-
lecular targets to specifically modulate migDCs and promote
immunity or tolerance.Immunity 42, 627–639, April 21, 2015 ª2015 Elsevier Inc. 637
EXPERIMENTAL PROCEDURES
Detailed experimental procedures are described in the Supplemental Informa-
tion section.
Mice
K5-mOVA, OT-I, OT-II, Ccr7/, and Tg(Itgax-hBcl2) mice have been previ-
ously described (Azukizawa et al., 2003; Hogquist et al., 1994; Barnden
et al., 1998; Fo¨rster et al., 1999; Gautier et al., 2009).
Flow Cytometry
Anti-CD11c (HL3), anti-CD8a (53-6.7), anti-MHC II (M5/114), anti-CD45.2
(104), anti-CCR7 (4B12), anti-CD11b (M1/70), anti-CD24 (M1/69), anti-Foxp3
(FJK-16 s), and anti-CD103 (M290) antibodies were all purchased from either
BDeBioscience or Biolegend. Anti-Fascin (EP5902) antibody was purchased
from Abcam. H-2Kb-OVA257-264 PE tetramers were purchased from
Beckman Coulter. Analysis was performed with FACSCanto system (BD)
and Flowjo software (Tree Star).
Microarray Analysis
Microarray analyses were performed as reported previously (Yamakita et al.,
2011). The genes differentially expressed between steady-state dDCs and
migDCs were identified with the Bioconductor Limma statistical package,
with cutoff values of 0.05 for the false discovery rate and of 2 for the fold
change. A pathway analysis was then performed on the 1,095 genes upregu-
lated in migDCs via the Ingenuity Pathway Analysis facility. Distant regulatory
elements analysis was performed with default parameters and a motif search
with the Clover software as previously reported (Baranek et al., 2012); p value
threshold and score were fixed respectively at 0.05 and 4.
Skin Explants
Ears were split into ventral and dorsal parts and floated split side down on 1ml
medium containing RPMI 10% FCS and 50 mM b-mercaptoethanol.
Isolation of Skin DCs
Epidermis was separated from the dermis and single-cell suspensions were
prepared and cultured for 18 hr at 37C prior to analysis by flow cytometry.
For inhibitor experiments, single-cell suspensions of skin DCs were prepared
from epidermis and treated with or without various inhibitors for 18 hr at 4C
or 37C: IKKb inhibitor BI605906 (Zhang et al., 2014), 10 and 50 mM; JAK3
inhibitor CP690550 (Tocris), 1 mM; anti-mouse TGF-b1 neutralizing Ab
(Uyttenhove et al., 2011), 10 mg/ml; anti-mouse CSF2 neutralizing Ab
(eBioscience), 5 mg/ml.
Adoptive T Cell Transfer
OT-I and OT-II cells were purified from pooled LNs and spleen by negative
selection via a T cell isolation kit (Invitrogen); CD25 OT-II cells were subse-
quently sorted by flow cytometry using anti-CD4 and anti-CD25 antibodies.
BrdU Labeling In Vivo
Mice were injected i.p. with 1.5 mg of BrdU (Sigma Aldrich) and their drinking
water was supplemented with 0.8 mg/ml BrdU and 2% glucose. BrdU staining
was performed according to the manufacturer’s recommendations (BrdU
labeling Flow kit, BD).
FITC Painting
FITC (0.5 mg/ml) was dissolved in acetone and dibutyl phthalate 1:1 and 30 ml
was applied on the ear of anesthetized mice.
Topical Immunization
50 mg of H-2Kb-OVA257-264 peptide was mixed in 50 mg of imiquimod cream
(Aldara; 3M Pharceuticals) and applied to ears of anesthetized animals.
Histopathology
Hematoxylin and eosin staining was perfomed on paraffin-embedded spleen
and kidney tissue. Immunohistochemistry was performed on frozen tissue
sections with the indicated antibodies. GC development was evaluated via
the following scoring: 1, weak; 2, moderate; 3, marked; 4, high. Serum was638 Immunity 42, 627–639, April 21, 2015 ª2015 Elsevier Inc.analyzed for autoantibody production by a standard autoantibody test with
Hep-2 cells fixed on slides (Biomedical Diagnosis).
Statistical Analysis
p values were calculated with either the Mann-Whitney test or the Fisher test
when appropriate with Graph pad prism software.
SUPPLEMENTAL INFORMATION
Supplemental Information includes six figures and Supplemental Experimental
Procedures and can be found with this article online at http://dx.doi.org/10.
1016/j.immuni.2015.03.003.
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